DOD funds trial of exercise program for Parkinson’s swallowing
A $1.9 million U.S. Department of Defense–funded Phase 2 clinical trial will test SwallowFIT, a targeted exercise program designed to…
Articles by Margarida Maia, PhD
Oral bacteria can colonize the gut, help drive Parkinson’s, study shows
People with Parkinson’s disease have an increased abundance of the oral bacteria Streptococcus mutans — typically found in the…
Lasting relief of Parkinson’s motor symptoms found with DBS
Deep brain stimulation (DBS) can provide lasting relief from motor symptoms and help people with Parkinson’s disease function…
Parkinson’s therapy ARV-102 able to reach brain, where needed: Study
ARV-102, an oral therapy Arvinas is developing for people with Parkinson’s disease, was shown to reach the brain…
GT-02287 safely eases Parkinson’s motor symptoms in study
The oral therapy GT-02287, being developed by Gain Therapeutics for people with Parkinson’s disease with or without mutations…
Abbvie asks FDA to approve tavapadon as Parkinson’s treatment
Abbvie has submitted an application to the U.S. Food and Drug Administration (FDA) seeking approval of tavapadon as a…
First patient dosed in Phase 3 trial of bemdaneprocel for Parkinson’s
The first patient has been dosed in exPDite-2, a registrational Phase 3 clinical trial testing the safety and efficacy of…
Gain extends trial of Parkinson’s treatment GT-02287 for 9 months
Gain Therapeutics has launched a nine-month extension of its clinical trial testing GT-02287 as a Parkinson’s disease treatment.
Roundtable in US capital aims to help shape Parkinson’s care
A roundtable in the U.S. capital, hosted by the Parkinson’s Foundation, is aiming to find new ways to improve access…
MIND diet may slow Parkinson’s progression, study finds
A study showed that following the MIND diet — one that’s rich in vegetables, whole grains, legumes, nuts, and berries,…